Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 3
2005 5
2006 7
2007 5
2008 14
2009 7
2010 14
2011 7
2012 17
2013 9
2014 15
2015 21
2016 10
2017 15
2018 9
2019 10
2020 13
2021 13
2022 18
2023 16
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

219 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Autoantibodies.
Holmdahl R, Nimmerjahn F, Ludwig RJ. Holmdahl R, et al. Among authors: nimmerjahn f. Front Immunol. 2019 Apr 2;10:484. doi: 10.3389/fimmu.2019.00484. eCollection 2019. Front Immunol. 2019. PMID: 31001243 Free PMC article. No abstract available.
Stunning of neutrophils accounts for the anti-inflammatory effects of clodronate liposomes.
Culemann S, Knab K, Euler M, Wegner A, Garibagaoglu H, Ackermann J, Fischer K, Kienhöfer D, Crainiciuc G, Hahn J, Grüneboom A, Nimmerjahn F, Uderhardt S, Hidalgo A, Schett G, Hoffmann MH, Krönke G. Culemann S, et al. Among authors: nimmerjahn f. J Exp Med. 2023 Jun 5;220(6):e20220525. doi: 10.1084/jem.20220525. Epub 2023 Mar 28. J Exp Med. 2023. PMID: 36976180 Free PMC article.
Immunoglobulin G-dependent inhibition of inflammatory bone remodeling requires pattern recognition receptor Dectin-1.
Seeling M, Pöhnl M, Kara S, Horstmann N, Riemer C, Wöhner M, Liang C, Brückner C, Eiring P, Werner A, Biburger M, Altmann L, Schneider M, Amon L, Lehmann CHK, Lee S, Kunz M, Dudziak D, Schett G, Bäuerle T, Lux A, Tuckermann J, Vögtle T, Nieswandt B, Sauer M, Böckmann RA, Nimmerjahn F. Seeling M, et al. Among authors: nimmerjahn f. Immunity. 2023 May 9;56(5):1046-1063.e7. doi: 10.1016/j.immuni.2023.02.019. Epub 2023 Mar 21. Immunity. 2023. PMID: 36948194 Free article.
Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment.
Haake M, Haack B, Schäfer T, Harter PN, Mattavelli G, Eiring P, Vashist N, Wedekink F, Genssler S, Fischer B, Dahlhoff J, Mokhtari F, Kuzkina A, Welters MJP, Benz TM, Sorger L, Thiemann V, Almanzar G, Selle M, Thein K, Späth J, Gonzalez MC, Reitinger C, Ipsen-Escobedo A, Wistuba-Hamprecht K, Eichler K, Filipski K, Zeiner PS, Beschorner R, Goedemans R, Gogolla FH, Hackl H, Rooswinkel RW, Thiem A, Roche PR, Joshi H, Pühringer D, Wöckel A, Diessner JE, Rüdiger M, Leo E, Cheng PF, Levesque MP, Goebeler M, Sauer M, Nimmerjahn F, Schuberth-Wagner C, von Felten S, Mittelbronn M, Mehling M, Beilhack A, van der Burg SH, Riedel A, Weide B, Dummer R, Wischhusen J. Haake M, et al. Among authors: nimmerjahn f. Nat Commun. 2023 Jul 20;14(1):4253. doi: 10.1038/s41467-023-39817-3. Nat Commun. 2023. PMID: 37474523 Free PMC article.
Dangerous B-cell clones.
Greinacher A, Nimmerjahn F. Greinacher A, et al. Among authors: nimmerjahn f. Blood. 2022 Oct 13;140(15):1663-1665. doi: 10.1182/blood.2022017339. Blood. 2022. PMID: 36227751 Free PMC article. No abstract available.
Editorial: Effector functions of therapeutic antibodies.
Boross P, Peipp M, Nimmerjahn F. Boross P, et al. Among authors: nimmerjahn f. Front Immunol. 2023 Jan 12;13:1126966. doi: 10.3389/fimmu.2022.1126966. eCollection 2022. Front Immunol. 2023. PMID: 36713416 Free PMC article. No abstract available.
219 results